Access cutting-edge sepsis treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access sepsis specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sepsis treatment provided free
This study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on adult patients (18 to 85 years) hospitalized due to a serious infection (called "sepsis") and receiving standard-of-care medications for low blood pressure (called "vasopressors") due to sepsis. The aim of the study is to see how safe, tolerable, and effective the study drug is by observing the effects on blood pressure and the total amount of vasopressor dose received during the stay i
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this sepsis clinical trial in New Haven, CT
If you're searching for sepsis treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sepsis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.